Clinical Trial 40412


Las Vegas, NV 89102

Study Summary:

The ADVANCE Study is recruiting seniors 65 to 90 years of age who have been diagnosed with Alzheimer’s disease and are experiencing agitation symptoms to take part in a clinical research study. The purpose of the study is to determine the safety and effectiveness of an investigational medication for agitation in patients with Alzheimer’s disease.

Qualified Participants Must:

• Be 65 to 90 years of age
• Have a diagnosis of probable Alzheimers disease
• Have a caregiver who is willing and able to comply with the study instructions
• Have symptoms of agitation/aggression. e.g. throwing things, hitting, yelling, pacing, repeating questions, inappropriate undressing, sneaking out

Qualified Participants May Receive:

Individuals will be evaluated to determine their eligibility to participate in the study. If eligible, study participants will receive the study drug (AXS-05), an active control (bupropion), or a placebo control (inactive substance) orally as a tablet taken twice daily for five consecutive weeks. All three products look identical, but only AXS-05 contains the active drug intended to treat your loved one’s agitation. Study participants will also receive study-related medical exams and laboratory tests at no cost. Compensation for time and travel may also be available.

Study is Available At:

Altea Research
3012 W Charleston Blvd. Suite 100
Las Vegas, NV 89102
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.